KOELIS

KOELIS is a MedTech company based in Grenoble, France, that specializes in advanced imaging and intervention technologies for prostate diseases, particularly prostate cancer. Founded in 2006, KOELIS is recognized for its leadership in 3D image fusion technology, which combines clinical research with innovative software and ultrasound hardware development. The company's flagship product, the KOELIS Trinity® platform, is a mobile system that integrates multiple imaging modalities, including MRI and real-time 3D ultrasound, using patented Organ-Based Tracking Fusion® technology. This system enables detailed 3D prostate mapping and targeted biopsy, enhancing diagnostic accuracy. KOELIS also offers a range of products, including 3D ultrasound probes, surgical workstations, and PROMAP-FT software for needle-based focal therapy. With a commitment to innovation and quality, KOELIS has treated over 350,000 patients worldwide and operates internationally, distributing its products in about 50 countries. The company aims to improve diagnostic confidence for healthcare professionals and enhance the quality of life for patients.

• Employees93
• Founded2006
• Total Funding$10849300